SOUL trial: Oral semaglutide demonstrates a 14% reduction in risk of major adverse CV events owenhaskins Oct 24, 2024 2 min read Headline results from the SOUL cardiovascular outcomes trial show the trial achieved its primary objective by demonstrating a statistically significant and superior reduction in major adverse cardiovascular events (MACE) of 14% for people treated with oral semaglutide compared to placebo (based on treatment policy estimand: treatment effect regardless of treatment adherence)
When used as part of a medical weight loss program and prescribed for patients who qualify for its use for weight management, Semaglutide is effective for weight loss
Combat it with: 25-35g fiber daily (vegetables, fruits, whole grains, legumes) 2-3+ liters of water daily Magnesium glycinate supplement (200-400mg before bed helps with both constipation and sleep) Carbs around training: Dont eliminate carbs
, - , ()
The reasons why you are looking for answers here could be that your supply got disrupted, the cost has gone up, your provider has changed, or maybe your clinician has a clinical reason to recommend Wegovy instead
This means reading every label: sucrose, fructose, maltose, corn syrup, agave, and honey all feed Candida equally
